These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 482744)

  • 1. [Experimental pulmonary hypertension--with special reference to physiopathology and etiology of pulmonary hypertension caused by monocrotaline].
    Watanabe S
    Kokyu To Junkan; 1979 Jan; 27(1):4-11. PubMed ID: 482744
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental study on monocrotaline induced pulmonary hypertensive rats. (1) Effect of long-term injection of immunosuppressant.
    Tanabe T; Furuya H; Kanemoto N; Goto Y; Hata J
    Tokai J Exp Clin Med; 1981 Jan; 6(1):41-8. PubMed ID: 6789505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary circulatory disturbance due to pulmonary peripheral lesions--etiology of experimental pulmonary hypertension and cor pulmonale].
    Watanabe S
    Kokyu To Junkan; 1981 May; 29(5):481-5. PubMed ID: 6797009
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathophysiological study on monocrotaline-induced pulmonary hypertension in rats (author's transl].
    Kido M
    Fukuoka Igaku Zasshi; 1981 Mar; 72(3):117-30. PubMed ID: 6790398
    [No Abstract]   [Full Text] [Related]  

  • 5. [The mechanism of the development of pulmonary hypertension induced by monocrotaline in rats].
    Kataoka R; Tobise K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 May; 25(5):563-73. PubMed ID: 3118089
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monocrotaline-induced pulmonary hypertension with special reference to the influence of dose, age, and sex].
    Sawada A; Kuriyama T; Sugita T; Watanabe S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 May; 23(5):578-83. PubMed ID: 3932735
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
    Altiere RJ; Olson JW; Gillespie MN
    J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
    Kakusaka I; Kaneko N; Kiyatake K; Fujita A; Suzuki A; Nakano K; Okada O; Sugita T; Watanabe S; Kuriyama T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):51-6. PubMed ID: 2501548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphological study of monocrotaline-induced pulmonary hypertension in rats].
    Nakashima M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Mar; 21(3):227-39. PubMed ID: 6415328
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reduction of the development of monocrotaline-induced pulmonary hypertension in rats by artificial unilateral pneumothorax].
    Sugita T; Sawada A; Kuriyama T; Yamagishi F; Kohchi F; Naitoh T; Kakusaka I; Okada O; Watanabe S; Ogata T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov; 23(11):1328-36. PubMed ID: 3937926
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in main pulmonary artery of rats with monocrotaline-induced pulmonary hypertension.
    Guzowski DE; Salgado ED
    Arch Pathol Lab Med; 1987 Aug; 111(8):741-5. PubMed ID: 3115224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mast cell hyperplasia in monocrotaline-induced pulmonary changes in rats].
    Kuriyama T; Sawada A; Sugita T; Watanabe S; Shen SY; Hiroshima K; Hayashi Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Aug; 23(8):865-72. PubMed ID: 3935842
    [No Abstract]   [Full Text] [Related]  

  • 14. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic detection of pulmonary hypertension in anesthetized rats.
    Cottrill CM; Johnson GL; Gillespie MN
    Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):189-96. PubMed ID: 2969131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy.
    Mathew R; Gloster ES; Altura BT; Altura BM
    Microcirc Endothelium Lymphatics; 1990; 6(4-5):267-83. PubMed ID: 2149161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single lung transplantation in rats with chemically induced pulmonary hypertension.
    Kawaguchi AT; Mizuta T; Matsuda H; Shirakura R; Nakahara K; Tanaka H; Kawashima Y
    J Thorac Cardiovasc Surg; 1992 Mar; 103(3):483-9. PubMed ID: 1532040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocrotaline pyrrole-induced pulmonary hypertension in fawn-hooded rats with platelet storage pool deficiency: 5-hydroxytryptamine uptake by isolated, perfused lungs.
    Hilliker KS; Bell TG; Roth RA
    Thromb Haemost; 1983 Dec; 50(4):844-7. PubMed ID: 6665765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary pulmonary hypertension, a review.
    Widimský J
    Cor Vasa; 1982; 24(5):309-17. PubMed ID: 6816507
    [No Abstract]   [Full Text] [Related]  

  • 20. Right ventricle-sparing heart transplantation effective against iatrogenic pulmonary hypertension.
    Lovoulos C; Tittle S; Goldstein L; Austin DJ; Singh S; Rocco E; Keane J; Tang P; Kopf GS; Elefteriades JA
    J Heart Lung Transplant; 2004 Feb; 23(2):236-41. PubMed ID: 14761772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.